brain pacemaker market size, brain pacemaker market growth, brain pacemaker industry analysis, brain pacemaker market demand, brain pacemaker market trends, brain pacemaker market outlook
What is the current market size and future outlook for the brain pacemaker market?
The brain pacemaker market size has grown rapidly in recent years. It will grow from $1.57 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to increasing prevalence of Parkinson’s disease, continuous improvements in neuromodulation technologies, clinical success and approvals, rising awareness of movement disorders, rising healthcare expenditure.
The brain pacemaker market size is expected to see rapid growth in the next few years. It will grow to $3.19 billion in 2029 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to aging population, increased awareness and better diagnostic techniques for neurological conditions, expanding indications, improved surgical techniques, obtaining regulatory approvals for new devices, patient preference for non-pharmacological treatments. Major trends in the forecast period include advanced targeting algorithms, development of closed-loop DBS systems, integration of wireless charging capabilities, advancements in minimally invasive surgical techniques, innovations in battery technology.
Get Your Free Sample of The Global Brain Pacemaker Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16634&type=smp
How has the brain pacemaker market evolved, and what factors have shaped its growth?
The growing incidence of neurological illnesses is expected to propel the growth of the brain pacemaker market going forward. Neurological illnesses, also known as neurological disorders, are conditions that affect the nervous system. The growing incidence of neurological illnesses is primarily due to an aging population, lifestyle habits, environmental exposures, genetic predispositions, infectious diseases, traumatic injuries, healthcare disparities, and the effects of urbanization and industrialization. A brain pacemaker helps in neurological illnesses by delivering targeted electrical impulses to regulate abnormal brain activity, alleviating symptoms, and improving the quality of life for patients with neurological conditions. For instance, in October 2023, according to the World Federation of Neurology, a UK-based association of national neurological societies, over 40% of the global population suffers from some neurological condition, which is projected to nearly double by 2050. Further, the number of people who die from stroke globally is estimated to be 9.7 million deaths per year, which is expected to increase by 50% by 2050. Therefore, the growing incidence of neurological illnesses is driving the growth of the brain pacemaker market.
What are the major segments of the brain pacemaker market?
The brain pacemaker market covered in this report is segmented –
1) By Type: Single Channel, Dual Channel
2) By Application: Dystonia, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder, Parkinson’s Disease, Other Applications
3) By Sales Channel: Channel Sales, Direct Sales
4) By End-User: Hospitals, Ambulatory Surgical Centers And Clinics, Other End-Users
Subsegments:
1) By Single Channel: Implantable Single Channel Brain Pacemakers, Wearable Single Channel Brain Pacemakers
2) By Dual Channel: Implantable Dual Channel Brain Pacemakers, Wearable Dual Channel Brain Pacemakers
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/brain-pacemaker-global-market-report
Which companies dominate the brain pacemaker market?
Major companies operating in the brain pacemaker market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, LivaNova PLC, Renishaw plc, Beijing PINS Medical Co. Ltd., NeuroPace Inc., SPR Therapeutics, SceneRay Co. Ltd., Nexeon MedSystems Inc., Soterix Medical Inc., BrainsGate Ltd., Functional Neuromodulation Inc., Aleva Neurotherapeutics SA, NeuroSigma Inc., NeuroOne Medical Technology, Fisher Wallace Laboratories Inc., Bioinduction Limited, Neuronetics Inc., Synchron Inc., Neuro Device Group S.A.
How will evolving trends contribute to the growth of the brain pacemaker market?
Major companies operating in the brain pacemaker market are developing innovative products with advanced technologies, such as BrainSense technology, to enhance the precision and personalization of deep brain stimulation therapies. BrainSense technology captures and records brain signals, providing real-time data to personalize and optimize deep brain stimulation therapy. For instance, in January 2024, Medtronic, a US-based medical technology company, introduced the Percept RC deep brain stimulation (DBS) system. The Percept RC is the smallest and thinnest dual-channel neurostimulator available for DBS, featuring Medtronic’s exclusive BrainSense technology. DBS therapy use a surgically implanted medical device, identical to a cardiac pacemaker, to administer electrical stimulation to precisely specified locations. BrainSense technology enables the Percept RC to capture and record brain signals, offering valuable insights that allow healthcare providers to adapt and personalize DBS therapy to meet the patient’s evolving needs.
What are the key regional dynamics of the brain pacemaker market, and which region leads in market share?
North America was the largest region in the brain pacemaker market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain pacemaker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Brain Pacemaker Market Report 2025 Offer?
The brain pacemaker market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Brain pacemaker refers to an implantable medical device used to treat neurological conditions such as Parkinson’s disease and epilepsy. It consists of electrodes implanted in specific brain regions, connected to a pulse generator implanted in the chest. The device sends electrical impulses to targeted areas of the brain to regulate abnormal brain activity.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16634
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
